Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.
Abraham AA, John TD, Keller MD, Cruz CRN, Salem B, Roesch L, Liu H, Hoq F, Grilley BJ, Gee AP, Dave H, Jacobsohn DA, Krance RA, Shpall EJ, Martinez CA, Hanley PJ, Bollard CM.
Abraham AA, et al. Among authors: cruz crn.
Blood Adv. 2019 Jul 23;3(14):2057-2068. doi: 10.1182/bloodadvances.2019000201.
Blood Adv. 2019.
PMID: 31292125
Free PMC article.